Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions - 1 Jun 2018

Yeo Khung-Keong, Armstrong Ehrin J, López Javier E, Chen Debbie C, Westin Gregory G, Li Chin-Shang, Anderson David, Hua Amy, Singapuri Anil, Amsterdam Ezra A, Chiamvimonvat Nipavan, Laird John R

Abstract excerpt

OBJECTIVES: Our aims were to examine the prevalence and genetic predictors of aspirin and clopidogrel high on-treatment platelet reactivity (HoTPR), and associated adverse cardiovascular outcomes in patients with peripheral arterial disease (PAD). BACKGROUND: The association of aspirin and clopidogrel HoTPR with outcomes in PAD remains unclear. METHODS: This is a prospective cohort study of patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiography
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspirin

Share to California

Share to Clopidogrel

Share to Peripheral Arterial Disease

Share to Platelet Aggregation Inhibitors

Share to Platelet Function Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 29411531
DOI: 10.1002/ccd.27453
PMCID: PMC5997520

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.PMID 29411531Read ↗

High on-clopidogrel platelet reactivity: genotyping can help to optimize antiplatelet treatment.Semantic proximity Read ↗

Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy.Semantic proximity Read ↗

Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.Semantic proximity Read ↗

Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.Semantic proximity Read ↗

Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment.Semantic proximity Read ↗

Genetic determinants of on-clopidogrel high platelet reactivity.Semantic proximity Read ↗

Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.Semantic proximity Read ↗

Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.Semantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

The Impact of Single Nucleotide Polymorphisms and Other Mechanisms on Aspirin Resistance.Semantic proximity Read ↗

Genetic and Clinical Determinants of MACE and Haemorrhage in Antiplatelet Therapy: Insights from Pharmacogenomic AnalysisSemantic proximity Read ↗

Genetically Determined Platelet Reactivity and Related Clinical Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.